Yonhap KoreanKO
유한양행 "만성신장병 신약 임상1상 계획 식약처 승인받아"
(서울=연합뉴스) 신선미 기자 = 유한양행[000100]은 만성신장병(CKD) 신약으로 개발 중인 'YH34180'의 임상 1상 시험계획(IND...
🇰🇷 대한민국 / 한국어
The world, in perspective.
Fresh headlines from around the world. Gaming, politics, technology and everything in between.
Allnira republishes accessible articles under owner-declared permissions, with original authors, publishers and image credits. Automatic cloud imports run hourly; open pages check for updates every 15 seconds. Publication delays depend on each feed.